EphrinB2-mediated CDK5/ISL1 pathway enhances cardiac lymphangiogenesis and alleviates ischemic injury by resolving post-MI inflammation.
- DOI
- 10.1038/s41392-024-02019-4
- Published
- 2024 Nov 18
- Container
- Signal transduction and targeted therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41392-024-02019-4,
title = {EphrinB2-mediated CDK5/ISL1 pathway enhances cardiac lymphangiogenesis and alleviates ischemic injury by resolving post-MI inflammation.},
author = {Bai Y and Chen L and Guo F and Zhang J and Hu J and Tao X and Lu Q and Li W and Chen X and Gong T and Qiu N and Jin Y and Yang L and Lei Y and Ruan C and Jing Q and Cooke JP and Wang S and Zou Y and Ge J},
year = {2024},
journal = {Signal transduction and targeted therapy},
doi = {10.1038/s41392-024-02019-4},
url = {https://doi.org/10.1038/s41392-024-02019-4}
}RIS
TY - JOUR TI - EphrinB2-mediated CDK5/ISL1 pathway enhances cardiac lymphangiogenesis and alleviates ischemic injury by resolving post-MI inflammation. AU - Bai Y AU - Chen L AU - Guo F AU - Zhang J AU - Hu J AU - Tao X AU - Lu Q AU - Li W AU - Chen X AU - Gong T AU - Qiu N AU - Jin Y AU - Yang L AU - Lei Y AU - Ruan C AU - Jing Q AU - Cooke JP AU - Wang S AU - Zou Y AU - Ge J PY - 2024 JO - Signal transduction and targeted therapy DO - 10.1038/s41392-024-02019-4 UR - https://doi.org/10.1038/s41392-024-02019-4 ER -
APA
Y, B., L, C., F, G., J, Z., J, H., X, T., Q, L., W, L., X, C., T, G., N, Q., Y, J., L, Y., Y, L., C, R., Q, J., JP, C., S, W., Y, Z., & J, G. (2024). EphrinB2-mediated CDK5/ISL1 pathway enhances cardiac lymphangiogenesis and alleviates ischemic injury by resolving post-MI inflammation.. Signal transduction and targeted therapy. https://doi.org/10.1038/s41392-024-02019-4
Source records
- pubmed · retrieved 2026-09-26T21:01:36.272Z